* We recommend a score >= 0.08 for meaningful Gene-Disease associations
GeneID | Gene_Symbol | DisGeNet_diseaseID | Disease_name | ![]() | DisGeNet_sourceDB |
3014 | H2AFX | C1458155 | Mammary Neoplasms | 0.202732912464814 | CTD_human;LHGDN |
3014 | H2AFX | C0017636 | Glioblastoma | 0.201098907136852 | BEFREE;CTD_human |
3014 | H2AFX | C0036341 | Schizophrenia | 0.200274726784213 | BEFREE;PSYGENET |
3014 | H2AFX | C0027643 | Neoplasm Recurrence, Local | 0.2 | CTD_human |
3014 | H2AFX | C0032578 | Polyploidy | 0.2 | CTD_human |
3014 | H2AFX | C0376628 | Chromosome Breakage | 0.2 | CTD_human |
3014 | H2AFX | C1449861 | Micronuclei, Chromosome-Defective | 0.2 | CTD_human |
3014 | H2AFX | C0023903 | Liver neoplasms | 0.0802747267842131 | BEFREE;RGD |
3014 | H2AFX | C0007787 | Transient Ischemic Attack | 0.08 | RGD |
3014 | H2AFX | C0020538 | Hypertensive disease | 0.08 | RGD |
3014 | H2AFX | C0027055 | Myocardial Reperfusion Injury | 0.08 | RGD |
3014 | H2AFX | C0038220 | Status Epilepticus | 0.08 | RGD |
3014 | H2AFX | C4277682 | Chemical and Drug Induced Liver Injury | 0.08 | RGD |
3014 | H2AFX | C0006142 | Malignant neoplasm of breast | 0.0089349588097725 | BEFREE;GAD |
3014 | H2AFX | C0004135 | Ataxia Telangiectasia | 0.00630436065958405 | BEFREE;LHGDN |
3014 | H2AFX | C0024305 | Lymphoma, Non-Hodgkin | 0.00596412134074105 | BEFREE;GAD;LHGDN |
3014 | H2AFX | C0017638 | Glioma | 0.00410654638587925 | BEFREE;LHGDN |
3014 | H2AFX | C0025202 | melanoma | 0.00410654638587925 | BEFREE;LHGDN |
3014 | H2AFX | C0678222 | Breast Carcinoma | 0.0038461749789834 | BEFREE |
3014 | H2AFX | C0005859 | Bloom Syndrome | 0.00328236603323995 | BEFREE;LHGDN |
3014 | H2AFX | C0020179 | Huntington Disease | 0.00328236603323995 | BEFREE;LHGDN |
3014 | H2AFX | C0043119 | Werner Syndrome | 0.00300763924902685 | BEFREE;LHGDN |
3014 | H2AFX | C0087012 | Ataxia, Spinocerebellar | 0.00273291246481375 | LHGDN |
3014 | H2AFX | C0004509 | Azoospermia | 0.002407028523288 | GAD |
3014 | H2AFX | C0005684 | Malignant neoplasm of urinary bladder | 0.002407028523288 | GAD |
3014 | H2AFX | C0028960 | Oligospermia | 0.002407028523288 | GAD |
3014 | H2AFX | C0033578 | Prostatic Neoplasms | 0.002407028523288 | GAD |
3014 | H2AFX | C0008626 | Congenital chromosomal disease | 0.0021978142737048 | BEFREE |
3014 | H2AFX | C0024299 | Lymphoma | 0.0016483607052786 | BEFREE |
3014 | H2AFX | C0332996 | Persistent embryonic structure | 0.0013736339210655 | BEFREE |
3014 | H2AFX | C0009402 | Colorectal Carcinoma | 0.0010989071368524 | BEFREE |
3014 | H2AFX | C0023473 | Myeloid Leukemia, Chronic | 0.0010989071368524 | BEFREE |
3014 | H2AFX | C0376358 | Malignant neoplasm of prostate | 0.0010989071368524 | BEFREE |
3014 | H2AFX | C0600139 | Prostate carcinoma | 0.0010989071368524 | BEFREE |
3014 | H2AFX | C1527249 | Colorectal Cancer | 0.0010989071368524 | BEFREE |
3014 | H2AFX | C2239176 | Liver carcinoma | 0.0010989071368524 | BEFREE |
3014 | H2AFX | C0035335 | Retinoblastoma | 0.0008241803526393 | BEFREE |
3014 | H2AFX | C3539878 | Triple Negative Breast Neoplasms | 0.0008241803526393 | BEFREE |
3014 | H2AFX | C3887505 | DYSFUNCTION - SKIN DISORDERS | 0.0008241803526393 | BEFREE |
3014 | H2AFX | C0007102 | Malignant tumor of colon | 0.0005494535684262 | BEFREE |
3014 | H2AFX | C0007131 | Non-Small Cell Lung Carcinoma | 0.0005494535684262 | BEFREE |
3014 | H2AFX | C0007137 | Squamous cell carcinoma | 0.0005494535684262 | BEFREE |
3014 | H2AFX | C0014859 | Esophageal Neoplasms | 0.0005494535684262 | BEFREE |
3014 | H2AFX | C0015625 | Fanconi Anemia | 0.0005494535684262 | BEFREE |
3014 | H2AFX | C0026764 | Multiple Myeloma | 0.0005494535684262 | BEFREE |
3014 | H2AFX | C0026769 | Multiple Sclerosis | 0.0005494535684262 | BEFREE |
3014 | H2AFX | C0029925 | Ovarian Carcinoma | 0.0005494535684262 | BEFREE |
3014 | H2AFX | C0036220 | Kaposi Sarcoma | 0.0005494535684262 | BEFREE |
3014 | H2AFX | C0079731 | B-Cell Lymphomas | 0.0005494535684262 | BEFREE |
3014 | H2AFX | C0079744 | Diffuse Large B-Cell Lymphoma | 0.0005494535684262 | BEFREE |
3014 | H2AFX | C0085390 | Li-Fraumeni Syndrome | 0.0005494535684262 | BEFREE |
3014 | H2AFX | C0152018 | Esophageal carcinoma | 0.0005494535684262 | BEFREE |
3014 | H2AFX | C0206682 | Follicular thyroid carcinoma | 0.0005494535684262 | BEFREE |
3014 | H2AFX | C0238198 | Gastrointestinal Stromal Tumors | 0.0005494535684262 | BEFREE |
3014 | H2AFX | C0242379 | Malignant neoplasm of lung | 0.0005494535684262 | BEFREE |
3014 | H2AFX | C0546837 | Malignant neoplasm of esophagus | 0.0005494535684262 | BEFREE |
3014 | H2AFX | C0684249 | Carcinoma of lung | 0.0005494535684262 | BEFREE |
3014 | H2AFX | C0699790 | Colon Carcinoma | 0.0005494535684262 | BEFREE |
3014 | H2AFX | C1140680 | Malignant neoplasm of ovary | 0.0005494535684262 | BEFREE |
3014 | H2AFX | C1306460 | Primary malignant neoplasm of lung | 0.0005494535684262 | BEFREE |
3014 | H2AFX | C1334274 | Invasive Carcinoma | 0.0005494535684262 | BEFREE |
3014 | H2AFX | C1336076 | Sporadic Breast Carcinoma | 0.0005494535684262 | BEFREE |
3014 | H2AFX | C1621958 | Glioblastoma Multiforme | 0.0005494535684262 | BEFREE |
3014 | H2AFX | C3463824 | MYELODYSPLASTIC SYNDROME | 0.0005494535684262 | BEFREE |
3014 | H2AFX | C3469521 | FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) | 0.0005494535684262 | BEFREE |
3014 | H2AFX | C0002871 | Anemia | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0003123 | Anorexia | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0004114 | Astrocytoma | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0004763 | Barrett Esophagus | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0005699 | Blast Phase | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0007103 | Malignant neoplasm of endometrium | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0007113 | Rectal Carcinoma | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0007134 | Renal Cell Carcinoma | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0007785 | Cerebral Infarction | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0009324 | Ulcerative Colitis | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0010674 | Cystic Fibrosis | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0011854 | Diabetes Mellitus, Insulin-Dependent | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0019163 | Hepatitis B | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0022593 | Keratosis | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0022602 | Actinic keratosis | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0022603 | Seborrheic keratosis | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0023418 | leukemia | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0023467 | Leukemia, Myelocytic, Acute | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0024141 | Lupus Erythematosus, Systemic | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0026847 | Spinal Muscular Atrophy | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0027627 | Neoplasm Metastasis | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0027666 | Neoplasms, Radiation-Induced | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0028754 | Obesity | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0029463 | Osteosarcoma | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0032463 | Polycythemia Vera | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0032580 | Adenomatous Polyposis Coli | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0033036 | Atrial Premature Complexes | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0034067 | Pulmonary Emphysema | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0038362 | Stomatitis | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0040028 | Thrombocythemia, Essential | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0041408 | Turner Syndrome | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0085281 | Addictive Behavior | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0085669 | Acute leukemia | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0149925 | Small cell carcinoma of lung | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0149978 | Adenocarcinoma of rectum | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0151468 | Thyroid Gland Follicular Adenoma | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0162565 | Acute intermittent porphyria | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0178874 | Tumor Progression | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0205647 | Follicular adenoma | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0206664 | Teratocarcinoma | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0238448 | Testicular embryonal carcinoma | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0265202 | Seckel syndrome | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0276275 | Disease due to Parvoviridae | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0278996 | Cancer of Head and Neck | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0279628 | Adenocarcinoma Of Esophagus | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0280100 | solid tumor | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0280785 | Diffuse Astrocytoma | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0333307 | Superficial ulcer | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0398791 | Nijmegen Breakage Syndrome | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0476089 | Endometrial Carcinoma | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0497406 | Overweight | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0521585 | Gastrointestinal mucositis | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0553580 | Ewings sarcoma | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0555198 | Malignant Glioma | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0585442 | Osteosarcoma of bone | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0596263 | Carcinogenesis | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0598766 | Leukemogenesis | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0740380 | varicella zoster | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0747742 | polyp benign | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0751072 | Frontotemporal Lobar Degeneration | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0751713 | Inclusion Body Myopathy, Sporadic | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0878500 | Intraepithelial Neoplasia | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C0917798 | Cerebral Ischemia | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C1136033 | Cutaneous Mastocytosis | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C1168401 | Squamous cell carcinoma of the head and neck | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C1337013 | Differentiated Thyroid Gland Carcinoma | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C1519670 | Tumor Angiogenesis | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C1527390 | Neoplasms, Intracranial | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C1568868 | Oral Mucositis | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C1858391 | ATAXIA-TELANGIECTASIA-LIKE DISORDER | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C1883486 | Uterine Corpus Cancer | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C2921627 | Clinically isolated syndrome | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C3203102 | Idiopathic pulmonary arterial hypertension | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C3828416 | Radiation Damage | 0.0002747267842131 | BEFREE |
3014 | H2AFX | C3887524 | Skin Erosion | 0.0002747267842131 | BEFREE |